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Background: Previous findings have shown that epilepsy can precipitate amnesia and anxiety, 
among other neuropsychiatric disorders. Bambusa vulgaris is used in African traditional 
medicine against convulsion, amnesia and anxiety but there is scanty scientific basis for these 
ethnomedicinal claims.  Hence, this study investigated the anticonvulsant, antiamnesic and anti-
anxiety effects of Bambusa vulgaris in mice. Methods: The acute oral ingestion of Bambusa 
vulgaris (100, 200 and 400 mg/kg) was investigated using pentylenetetrazole-, and strychnine-
induced convulsion; antiamnesic using scopolamine-, and diazepam-induced amnesic models 
while the anxiolytic effect was assessed using elevated plus maze models.  The phytochemical 
analysis was carried out using standard methods. Results: The extract at all the doses used 
significantly (p<0.05) elongated the death latency while at 400 mg/kg the onset of clonic and 
tonic convulsions were significantly (p<0.05) prolonged in pentylenetetrazole-induced 
convulsion model. The extract at 100, 200 and 400 mg/kg offered 60, 80 and 100% protection 
respectively in pentylenetetrazole-induced convulsion test. The extract showed no significant 
(p>0.05) effect on strychnine-induced convulsion model ruling out the involvement of 
strychnine-sensitive glycine receptor in the anticonvulsant effect of the extract. The extract at all 
the tested doses significantly (p<0.05) in a dose dependent fashion ameliorated the amnesia 
induced by scopolamine and diazepam suggesting antiamnesic effect. Bambusa vulgaris at all 
the tested doses significantly (p<0.05) in a dose dependent pattern increased the percentage open 
arm entries and percentage open arm duration on the open arm of the elevated plus maze as well 
as reduced the anxiety indices of the experimental mice consistent with anxiolytic effect. The 
phytochemical quantification of the extract showed abundance of tannins and corroborated by 
the findings from the Fourier transform infrared spectra of the extract. Conclusion: This study 
therefore concluded that Bambusa vulgaris may possess anticonvulsant, antiamnesic and 
anxiolytic effects and provided scientific proof for its traditional use. 
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INTRODUCTION   
 Epilepsy according to the World Health Organisation is 
a chronic non-communicable brain disorder 
characterized by seizure, which affect individuals of all 
age brackets (WHO, 2012; Kolawole et al., 2012). The 
currently available antiepileptic drugs target 
GABAergic, serotonergic, noradrenergic and 
dopaminergic     systems   involved in   inhibitory   and 
 
excitatory signals in the brain (Kolawole et al., 2012). 
Unfortunately, these antiepileptic drugs can only abolish 
seizure in nearly 70% of the patients suffering from 
epilepsy without complete remission in the remaining 
30% of the epileptic patients (Sander, 2004). 
Earlier research investigation has indicated that epilepsy 
can precipitate amnesia (Gallassi, 2006) and anxiety 
among other neuropsychiatric disorders (Uruaka and 
Georgwill, 2020). 
Anxiety has earlier been described as “a psychological, 
physiological, and behavioral state induced in animals 
and humans by a threat to well-being or survival, either 
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actual or potential.” (Steimer, 2002). It is associated with 
a wide range of psychiatric conditions such as epilepsy 
and neurodegenerative disorders (Stein et al., 1990). The 
major classes of drugs employed in the treatment of 
anxiety disorder are benzodiazepines and selective 
serotonin-reuptake inhibitors (SSRIs) (Parek and 
Chanda, 2006), but the undesirable effects linked with 
these classes of drugs (Kunovac and Stahl, 1995) have 
unfortunately limited their use. 
The undesirable effect associated with the synthetic 
anxiolytic drugs (Kunovac and Stahl, 1995) and the 
inability of the currently available antiepileptic drugs to 
control epileptic seizure (Stein et al., 1990), coupled 
with the untoward effects linked to acetylcholineesterase 
inhibitors used against amnesia (Baradaran et al., 2012) 
have undoubtedly warranted the search for novel 
anticonvulsant, antiamnesic and anxiolytic medications 
probably from medicinal plants. 
Bambusa vulgaris, commonly referred to as “Bamboo” 
(Carey et al., 2009) is a member of the Poaceae family. 
Bamboo is a large perennial grass dispersed widely from 
tropical to subarctic zones (Ambika and Rajagopal, 
2019) and commonly found in moist places such as the 
river banks (Khan and Hemalatha, 2015).  
The different parts of bamboo such as leaf, shoot, stem 
and sap are used as medicine in folkloric medicine. In 
Nigerian folkloric medicine, bamboo is reported to be 
used in the management of gonorrhea, respiratory 
diseases, as arbotifacient, as well as an emmenagogue 
and appetizer (Yakubu and Bukoye, 2009). It is also used 
in Nigerian traditional medicine as anti-aging and 
memory enhancer (Elufioye et al., 2012). In Indian 
folkloric medicine, the leaves are used in the treatment 
of various inflammatory conditions (Carey et al., 2009). 
In Chinese ethnomedicine, bamboo is used to ease labor 
and placenta expulsion (Ambika and Rajagopal, 2019).   
The anti-inflammatory (Carey et al., 2009), antioxidant 
(Goyal et al., 2013), arbotifacient (Yakubu and Bukoye, 
2009), antimicrobial and antiproliferative (Ambika and 
Rajagopal, 2019) activities of Bambusa vulgaris have 
been reported. 
This study aimed to investigate the anticonvulsant, 
antiamnesia and anxiolytic potentials of Bambusa 
vulgaris in mice upon its use in traditional medicine as 
anticonvulsant, memory enhancer and anxiolytic agent 
(Clark et al., 1995; Ogunjimi et al., 2009; Elufioye et al., 
2012).  
 
MATERIALS AND METHODS 
Plant identification, collection and authentication 
Fresh leaves of Bambusa vulgaris were collected by Mr 
M.A Adebayo of the Department of Pharmacognosy, 
College of Pharmacy, Igbinedion University Okada. The 
collection was done within the temporary site of the 
Igbninedion University Campus Okada in Ovia North 
Eat Local Government of Edo State. The leaves were 
authenticated by Mr. G. A. Ademoriyo of the Herbarium 
Unit, Department of Botany, Faculty of Sciences, 
Obafemi Awolowo University, Ile-Ife and herbarium 
number IFE-17960 was obtained. 
 
Extraction of plant material 
The extraction protocols used in this study was as earlier 
reported (Velavan, 2015) with mild modification. 
Briefly, fresh leaves of Bambusa vulgaris were 
collected, shade dried and subsequently ground into 
powder with mechanical grinder. The powdered material 
was macerated in 70% methanol for 72 h. The resulting 
filtrate was concentrated in vacuo and subsequently 
freeze dried to yield 12.6 g (4.2 %) coded BV which was 
stored in a desiccator prior to use. The extract was 
dissolved with 3% Tween 80 and made up to the 
required volume with normal saline and prepared fresh 
on each day of the experiment. 
 
Experimental animals 
Adult male mice of between 18-25 g were purchased 
from the Central Animal House of the Igbinedion 
University Okada. The animals were fed with standard 
animal pellets with water ad libitum. The experimental 
guidelines followed in this research investigation were 
as approved and being implemented by the Igbinedion 
University Animal Ethical Committee which are in line 
with the internationally accepted principles for 
Laboratory Animal Use and Care (Waldegrave, 1986). 
 
Drugs 
Diazepam (DZP) (Roche, Basel, Switzerland); 
Pentylenetetrazol (PTZ), Strychnine (SCN), 
Scopolamine hydrobromide (SCOP), Piracetam 
(PIRAC), Tween 20 (Sigma Chemicals Co, St. Louis, 
Missouri, U.S.A.); Phenobarbitone (May and Baker, 
United Kingdom); and normal saline (Unique 
Pharmaceutical Limited, Lagos, Nigeria).  
 
Spectrophotometric phytochemical estimation 
 The tannin content, total flavonoids, total phenols and 
total alkaloids in BV were estimated as earlier reported 
in literature (Akinpelu et al., 2019a). 
 
Spectroscopic analyses of BV 
The extract was scanned at the wavelength range of 200-
900 nm to obtain the UV-VIS spectrum of BV using UV 
spectrophotometer. The FT-IR spectrum of BV was 
obtained after mixing the extract with the spectra-grade 
potassium bromide (KBr) in the ratio of 1:100 and 
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pressed into pellet. The pellet was immediately 
introduced into the sample holder of Perkin Elmer 
Spectrophotometer. The Spectrophotometer was 
operated in the range 4000 – 300 cm–1 to detect the 
spectra data of the different functional groups present in 
the extract (Akinpelu et al., 2019a).  
 
General experimental design 
Adult male albino mice were randomly sorted into five 
experimental groups (n=5). Group-I (negative control) 
mice received 3% Tween 80 in normal saline (10 mL/kg, 
p.o.). Group II-IV mice received BV (100, 200 or 400 
mg/kg, p.o.), while Group-V received intraperitoneal 
injection of positive control drug such as piracetam (200 
mg/kg, p.o.) for scopolamine and diazepam-induced 
amnesia; diazepam (1 mg/kg, i.p.) for anxiolytic and 
PTZ-induced convulsion experiments, while 
phenobarbitone (30 mg/kg, i.p.) was used as positive 
control drug in strychnine-induced convulsion model. 
 
Anticonvulsant tests 
Pentylenetetrazole (PTZ)- induced 
One hour post oral ingestion of BV (100, 200 and 400 
mg/kg) or half an hour post intraperitoneal treatment 
with diazepam (1 mg/kg), mice in all groups I-V mice 
were injected with the chemoconvulsant agent PTZ (85 
mg/kg, i.p.). Immediately after the intraperitoneal 
injection of PTZ, each mouse was gently put in an 
observation cage and observed for 30 minutes duration 
for the onset of clonic, tonic convulsions and death time 
which were recorded with cut off time of 30 minutes and 
the mice that survived beyond 30 minutes were 
considered protected (Swinyard et al., 1989; Akinpelu et 
al., 2018). 
 
Strychnine (SCN)-induced convulsion 
The experiment was carried out as above for PTZ-
induced convulsion except that strychnine (4 mg/kg, i.p.) 
was used as chemoconvulsant (Swinyard et al., 1989) 
and phenobarbitone (30 mg/kg, i.p.) as positive control 




Thirty minutes after oral ingestion of normal saline (10 
mL/kg) in group I, BV (100, 200 and 400 mg/kg, p.o.) in 
groups II-IV and piracetam (200 mg/kg, p.o.) in group 
V, scopolamine (1 mg/kg) was intraperitoneally injected 
to each mouse in groups I-V, thirty minutes after 
scopolamine injection, each mouse was observed on Y-
maze (40 x 3 x 12) with angles of 1200 between each of 
the three arms and the sequence of arms visited on 
consecutive choices in 8 minutes was recorded. The 
number of triads was recorded as ‘percentage 
alternation’ which indicates the assessment of short-term 
memory (Sarter et al., 1988; Akinpelu et al., 2020), 
according to this equation: An alternation is defined as 
an entry into all three arms on consecutive choices% 
Alternation = [(Number of alternations)/ (Total arm 
entries -2)] x 100. 
 
Diazepam-induced amnesia 
The experiment was carried out as above for 
scopolamine-induced amnesia, but diazepam (1 mg/kg, 
i.p.) was administered to induce amnesia instead of 
scopolamine (Akinpelu et al., 2020). 
 
Anxiolytic test 
Elevated plus maze (EPM): 
The test was conducted as recently carried out and 
reported in literature (Akinpelu et al., 2019a). After the 
respective oral ingestion with BV or intraperitoneal 
administrations with piracetam, each mouse was singly 
placed in the central square of the EPM facing one of the 
open arms and the number of entries into the open arm 
and the time spent on the open arm were noted with a 
stopwatch and recorded manually for a period of 5 
minutes. 
The open arm avoidance index interpreted as level of 
anxiety (Trullas and Skolnick, 1993) is calculated as   
 
                  
Statistical analysis 
Results are expressed as mean ± S.E.M and analysed 
using one-way analysis of variance (ANOVA), followed 
by Dunnett’s post hoc analysis. GraphPad InStat® 
Biostatistics software (GraphPad Software, Inc., La 
Jolla, USA) was employed as the statistical tool. The 
level of significance for all tests was set at p <0.05 
compared to the control group. 
 
RESULTS 
Effect of Bambusa vulgaris on PTZ-induced convulsion 
model 
The extract at 100 and 200 mg/kg showed significant 
(p<0.05) prolongation of death time and offered 60 and 
80% protection respectively compared to the control 
which offered 0% protection. The extract at 400 mg/kg 
significantly (p<0.05) elongated the onset of clonic, 
tonic convulsions, death latency and offered 100% 
protection. The result is presented in Table 1. 
 
Effect of Bambusa vulgaris on SCN-induced convulsion 
model 
The extract at all the doses used elongated the onset of 
clonic,   tonic   convulsions and   death time   but   not  
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Table 1: Effect of BV on PTZ-, and SCN-induced 
convulsions in mice. 
 
Values are Mean ± SEM, ANOVA; one-way analysis of variance 
followed by Dunnett’s post hoc Test, n=5, *p<0.05 compared to 
control (ANOVA; Dunnett’s post hoc test).  
 
significant (p>0.05) from the control treated mice. No 
protection was as well offered at the the tested doses. 
However, Phenobarbitone (30 mg/kg, i.p., a positive 
control drug) significantly (p<0.05) prolonged the onset 
of clonic, tonic convulsions, death latency and offered 
50% protection. The result is presented in Table 1.  
 
Effects of BV on percentage alternation in scopolamine-
induced amnesia on Y-Maze task. 
Scopolamine significantly (p<0.05) lowered the 
percentage correct alternation on Y-maze when 
compared to the control treated control group. However, 
BV significantly (p<0.05) and in a dose dose dependent 
pattern increased the reduced alternation induced by 
Scopolamine when compared to the Scopolamine treated 
control group. Piracetam, a positive control drug 
significantly (p<0.05) reversed the reduced alternation 
induced by Scopolamine in mice. The result is presented 
in Fig. 1 (Panel A). 
 
Effects of BV on percentage alternation in Diazepam-
induced amnesia in Y-Maze task. 
Diazepam showed significantly (p<0.05) reduction in 
the percentage correct alternation on Y-maze when 
compared to the control treated control group. However, 
BV showed significant (p<0.05) reversal in a dose 
dependent manner the reduced alternation induced by 
Diazepam when compared to the Diazepam treated 
control group. Piracetam, a positive control drug 
significantly (p<0.05) attenuated the reduced alternation 
 
 
Fig. 1: Effect of Bambusa vulgaris on percentage alternation in scopolamine-induced amnesia (Panel A) and diazepam-induced amnesia 
(Panel B) in mice. Each bar represents Mean ± SEM, n=5.  #p<0.05 and *p<0.05 compared to the control and scopolamine scopolamine 
(Panel A) or diazepam (Panel B) treated mice respectively (ANOVA; Dunnett’s post hoc test). 
 
 induced by Diazepam in mice. The result is presented in 
Fig. 1 (Panel B). 
 
Effect of Bambusa vulgaris on percentage open arm 
entries  
The   extract   significantly   (p<0.05)  and dose  dependently 
increased the percentage number of entries into the open 
arm of the elevated plus maze when compared to the 
control mice. The effect of the extract at 400 mg/kg is 
comparable to diazepam (1 mg/kg, i.p., a positive control 
drug). The result is presented in Fig. 2 (Panel A). 
 
Effect of Bambusa vulgaris on percentage open arm 
duration  
The extract of Bambusa vulgaris significantly (p<0.05) 
and dose dependently increased the percentage time 
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Fig. 2: Effect of Bambusa vulgaris on percentage open arm entries (Panel A) and Percentage open arm duration (Panel B) on 
elevated plus maze. Each bar represents Mean ± SEM, n=5.  *p<0.05 compared to the control treated mice.  
 
 
Table 2: Quantitative phytochemical analysis of 
methanol leaf extract of Bambusa vulgaris 
 
Values are means of triplicate determination ± Standard 
deviation; where AE is atropine equivalent, GAE is gallic acid 
equivalent, QE is quercetin equivalent and AE is atropine 
equivalent respectively. 
 
spent on open arms of the elevated plus maze when 
compared to the control mice. The effect of the extract 
at 400 mg/kg is comparable to diazepam (1 mg/kg, i.p., 
a positive control drug). The result is presented in Fig. 2 
(Panel B).   
 
Effect of Bambusa vulgaris on open arm avoidance 
index (OAAI)  
The extract showed at least a ten-point reduction in 
anxiety index of open arm avoidance index in a dose 
dependent manner when compared to the control treated 
mice. The effect of the extract at 400 mg/kg is 
comparable to diazepam (1 mg/kg, i.p., a positive control 
drug). The result is resented in Fig. 3.   
 
 
Fig. 3: Effect of Bambusa vulgaris on anxiety index on 
elevated plus maze. Each bar represents Mean ± SEM, n=5.  If 
the anxiety index is at least 10 point less than the vehicle 
treated control group, the sample is anxiolytic, conversely if 
the anxiety index is at least 10 points greater than the vehicle 
treated control group, then the sample is anxiogenic. 
 
 
Result of quantitative phytochemical quantification of 
Bambusa vulgaris  
The result showed that Tannin content > total 
flavonoids > total phenols > total alkaloids. The result 
is presented in Table 3. 
 
UV-VIS Spectrum Peak values of BV 
The UV-VIS spectrum of BV showed absorption peaks 
at 209.0, 296.5, 349.0, 490.0, 496.5, 556.5, 604.0, 663.5, 
680.5, 691.0, 718.0, 725.0, 732.5, 752.5, 760.5, 766.5, 
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Table 3: FTIR profile of methanol leaf extract of 
Bambusa vulgaris   
 
 
797.5, 837.5, 849.0, 863.0 and 888.5 nm and the 
absorption of 3.776, 0.681, 0.463, 0.027, 0.021, 0.010, 
0.005, 0.010, 0.010, 0.003, 0.002, 0.002, 0.001, 0.005, 
0.007, 0.004, 0.003, 0.003, 0.005, 0.006 and 0.004 
respectively (Fig. 4). 
 
FTIR spectrum of BV 
Table 2 revealed the FTIR spectrum of BV which showed 
characteristic bands at 3302.4, 2944.6, 2832.8, 1636.3, 
1449.9, 1397.8, 1338.1, 1110.7, 1017.6 and 641.1 cm-1. 
The result is presented in Table 4. 
 
DISCUSSION 
The present investigation assessed the anxiolytic and 
anticonvulsant potentials of methanol leaf extract of 
Bambusa vulgaris and the probable phytocompounds 
responsible for these pharmacological effects. The 
extract demonstrated anticonvulsant, antiamnesic and 
anxiolytic effects with tannins being the most abundant 
phytoconstituents assayed.  
 
The prolongation of the onset of clonic, tonic 
convulsions and death latency coupled with the varying 
degree of protection at the tested doses in PTZ-induced 
convulsion model suggest that the extract may possess 
anticonvulsant effect. This finding is in consonance with 
earlier suggestion of medicinal plant agent that showed 
anticonvulsant effect in PTZ-induced convulsion in mice 
(Akinpelu et al., 2018). 
 
The anticonvulsant effect of the extract may be acting 
via GABAA-benzodiazepine receptor neurotransmission 
since GABAergic pathway is key to the anticonvulsant 
potential of medicinal agents in PTZ induced convulsion 
models (Akinpelu et al., 2018). 
 
 
Fig. 4 (Left): UV-VIS spectrum profile of methanol leaf extract of Bambusa vulgaris 
Fig. 5 (Right): FTIR spectrum profile of methanol leaf extract of Bambusa vulgaris 
 
 
The amelioration of the amnesia induced by 
scopolamine and diazepam by the extract suggests that 
the extract may have antiamnesic effect probably acting 
via central muscarinic cholinergic and/or GABAA-BDZ 
receptor neurotransmission to elicit the observed 
antiamnesic effects. Since scopolamine induces memory 
impairment via acting as an antagonist action at the 
central muscarinic cholinergic receptor, while diazepam 
induces memory deficit either via acting as either agonist  
central muscarinic cholinergic receptor, while diazepam 
induces memory deficit either via acting as either agonist 
or antagonist at the central GABAA-benzodiazepine 
receptor pathway (GABAA-BDZ) since GABAA-BDZ 
receptor complex have been earlier reported to control 
the release of acetylcholine (Vazquez and Baghdoyan, 
2003), a   neurotransmitter    pivotal    to  learning  and 
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memory (Halsemo et al., 2006). The finding of this study 
is in accordance to the earlier reports of medicinal plants 
with antiamnesic effects in mice (Akinpelu et al., 2019a; 
2020). 
The increase in number of open arm entries and time 
spent on the elevated plus maze suggest that the extract 
may have anxiolytic effect since increase in these 
parameters by medicinal plant has been attributed to an 
anxiolytic effect in previous report (Akinpelu et al., 
2019a). Although it was not part of the objective of this 
study, but it is of interest to note that methanol leaf 
extract of Bambusa vulgaris extracted with soxhlet 
extraction showed anti-anxiety effect at the higher 
intraperitoneal dose of 400 mg/kg in mice (Kaur et al., 
2019), but our study of the methanol leaf extract 
extracted with cold maceration showed anti-anxiety 
effect at the three tested doses of 100, 200 and 400 mg/kg 
via oral route in mice 
The extract may be exerting its anxiolytic effect via 
GABAA-benzodiazepine receptor neurotransmission 
since elevated plus maze has been reported to be 
sensitive to agents acting via this pathway (Nutt and 
Maizia, 2001).  
The qualitative phytochemical screening of medicinal 
plant extracts provides evidence for the existence of 
phytochemicals in such extracts while phytochemical 
estimation gives the quantity  of each phytochemical in 
a given plant extract. The quantitative phytochemical 
quantifications of BV in different extraction solvents 
have yielded different results. For instance, the aqueous 
leaf extract of BV have been shown to largely contain 
alkaloids with flavonoids being the least, whereas the pet 
ether extract showed the presence of phytosterols and 
tannins (Yakubu and Bukoye, 2009). Our result of 
phytochemical estimation of the methanol leaf extract 
showed tannins to be the most abundant and total 
alkaloids to be the least and subsequently provide 
corroborative quantitative data on the qualitative 
analysis of the methanol leaf extract earlier reported 
(Coffie et al., 2014). 
Earlier report has attributed the UV/vis absorption 
maxima in the range of 300-350, 330-420, and 400-550 
to the existence of flavonoids, phenolic acid and their 
derivatives and terpenoids respectively (Akinpelu et al., 
2019a). Since these absorption UV/vis absorption 
spectra were also found in BV, it would therefore not be 
out of place to also suggest that BV contained these 
phytocompounds. The absorption peaks in UV region 
400-420 nm and 600-660 nm may be attributed to 
quinones and chlorophylls respectively (Bunghez et al., 
2013; Akinpelu et al., 2019b). 
Earlier report on FT-IR broad absorption spectra in the 
region of 3550–3100 cm-1 has been linked to the OH 
stretch vibration of benzene nucleus and methylol group 
of tannin (Rajeswari and Jothiprakasam, 2017). Moreso 
that BV contained functional groups such as O-H, C-H, 
C=O, C=O-C aromatic and C-O earlier shown to be 
present in tannins (Grasel et al., 2015). These functional 
groups could further support the abundance of tannins 
and other phenolic compounds quantitatively assayed in 
the extract.  
 
CONCLUSION  
This study concluded that Bambusa vulgaris may 
possess anxiolytic and anticonvulsant effect. This study 
further concluded that tannin either in additive or 
synergy with other plant secondary metabolites may be 
responsible for the observed pharmacological potentials.  
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